| 000 | 01104 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250513094338.0 | ||
| 264 | 0 | _c19961025 | |
| 008 | 199610s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-199606000-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlak, A M | |
| 245 | 0 | 0 |
_aQuality assurance procedure for monitoring tacrolimus (FK506) concentrations in whole blood by IMx assay. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cJun 1996 |
||
| 300 |
_a267-72 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xblood |
| 650 | 0 | 4 | _aObserver Variation |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aTacrolimus _xblood |
| 700 | 1 | _aLizak, P P | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 18 _gno. 3 _gp. 267-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-199606000-00008 _zAvailable from publisher's website |
| 999 |
_c8735823 _d8735823 |
||